A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer
=============================================================================================================================================================================================================

* Pénélope Desroys du Roure
* Laurie Lajoie
* Aude Mallavialle
* Lindsay B Alcaraz
* Hanane Mansouri
* Lise Fenou
* Véronique Garambois
* Lucie Rubio
* Timothée David
* Loïs Coenon
* Florence Boissière-Michot
* Marie-Christine Chateau
* Giang Ngo
* Marta Jarlier
* Martin Villalba
* Pierre Martineau
* Valérie Laurent-Matha
* Pascal Roger
* Séverine Guiu
* Thierry Chardès
* Laurent Gros
* Emmanuelle Liaudet-Coopman